Trifluoroacetic acid → Trifluoroacetic acid
Reaction equation
[N:1]1[CH:6]=[CH:5][C:4]([C:7]2[C:15]3[C:10](=[CH:11][CH:12]=[C:13]([C:16]([NH2:18])=[O:17])[CH:14]=3)[N:9](C(C3C=CC=CC=3)(C3C=CC=CC=3)C3C=CC=CC=3)[N:8]=2)=[CH:3][CH:2]=1.C([SiH](CC)CC)C.[C:45]([OH:51])([C:47]([F:50])([F:49])[F:48])=[O:46]>CN(C=O)C>[C:45]([OH:51])([C:47]([F:50])([F:49])[F:48])=[O:46].[N:1]1[CH:6]=[CH:5][C:4]([C:7]2[C:15]3[C:10](=[CH:11][CH:12]=[C:13]([C:16]([NH2:18])=[O:17])[CH:14]=3)[NH:9][N:8]=2)=[CH:3][CH:2]=1Participants
6
Reactant 3
Product 2
Reagents, catalysts & solvents 1
Procedure
N—((R)-1-((S or R)-2-(Dimethylamino)-1-(2-fluorophenyl)-2-oxoethyl)piperidin-3-yl)-3-(pyridin-4-yl)-1-trityl-1H-indazole-5-carboxamide (53 mg, 0.071 mmol) was stirred in TFA (0.5 mL) at room temperature for 30 minutes. triethylsilane (0.015 mL, 0.093 mmol) was added and the reaction mixture diluted with DMF (1 mL). The solution was purified by reverse-phase, mass-triggered prep-HPLC. The product fraction was lyophilized to give the bis TFA salt of N—((R)-1-((S or R)-2-(dimethylamino)-1-(2-fluorophenyl)-2-oxoethyl)piperidin-3-yl)-3-(pyridin-4-yl)-1H-indazole-5-carboxamide as a white solid.
Workup
- customThe solution was purified by reverse-phase, mass-triggered prep-HPLC
Sources & evidence
- ORD record
- ord-0e2a952a85444505b81abab61ac420e0
- Source dataset
- uspto-grants-2015_04
- Patent number
- US08999957B2
Reaction notes
Loading…